Merging medicine’s timeless art with frontier science: Collaborating with @LeadOptik to embed OCT in biopsy tools→real-time, high-res imaging for earlier, more precise lung cancer detection. Sharper tools =better outcomes for patients. Thrilled for the future!#MedTech#LungCancer
Thrilled to share that LEADOPTIK has received FDA 510(k) clearance for our Last Inch Assessment™ (LIA) System for lung biopsy procedures.
Grateful to our incredible team, investors, advisors, and mentors for making this milestone possible.
https://t.co/HiE5uZaAS3
Exciting news! 🎉 LEADOPTIK has been awarded key patents across the US, Europe, and Asia for our imaging probe & nanophotonic design—the core of our real-time, in-vivo tissue imaging system. IP is more than paperwork, it’s strategy! Read more: https://t.co/ttaNvuWwJl #DeepTech
From Kuala Lumpur to Harvard, Dr. @alexchee shares his journey & bold vision for the future of interventional pulmonology — where the “last inch” of the biopsy matters most. Why LIA is more than an upgrade: it’s a shift.
Read more: https://t.co/GprZfOsJze
Fitting In, Not Standing Out
In bronchoscopy, complexity is a given. That’s why simplicity matters.
LIA-1 fits in — with:
✔️ Familiar needle feel
✔️ Imaging that clarifies
✔️ Workflow that respects yours
Read more: https://t.co/jwOR3UnmXG
https://t.co/jwOR3UnmXG
Access isn’t the challenge – it’s the last inch. LIA (Last Inch Assessment) uses Light, Optics, and Intelligence to transform every biopsy.
Optical imaging doesn’t disrupt workflows – it completes them.
Learn more: https://t.co/j5euWJELaf
Turning on the lights in lung cancer diagnosis: Traditional biopsies lack real-time feedback. LIA changes that with light-based, in-vivo visualization, ending blind biopsies. The end of blind biopsy is coming. #LungCancer#LightBasedBiopsy
https://t.co/oRCduOknap
Sony Innovation Fund has invested in @LeadOptik, a #medicalimaging company building a miniature imaging platform to deliver an image-guided biopsy for early lung cancer detection. https://t.co/3RCEZO8lKq
We are thrilled to share that we have raised $5 million in an oversubscribed Series Seed funding round. The funding was led by MetaVC Partners, with participation from @SOSV, @Sony_Innov_Fund, @TSVCap, ENEA, @arashf, @RayMuzyka, and others.
https://t.co/37JNXuHTm8
MedTech Innovator is thrilled to announce the 2022 Execution Award finalists! @bright_uro, @Endoluxe, @evoendo, @LeadOptik, and @SUTUREGARD will vie for the award at the MedTech Conference on Oct. 24. Congratulations!
Lung cancer is by far the leading cause of cancer death. @LeadOptik (CDL'22) is developing nano-optics endoscope hardware to image respiratory disease in the lungs. Learn more about their technology by watching their video!
https://t.co/thD7MTXRyN
@LeadOptik is building a precision medical imaging platform using metasurfaces to detect tumors at their earliest stages.
Please 'like' and share the following Youtube video to help Leadoptik win the $10,000 MedTech Innovator prize!
#innovation#tech
https://t.co/g2wtmIqbMi
I'm a huge fan of Reza and the technology his team is building. Lung cancer kills more people than any other cancer and current diagnosis methods are quite poor. LEADOPTIK will revolutionize how we detect tiny tumors in the future.
Here is our video for @MedTechAwards Best Video Competition. Like (on YouTube, link below) could help @LeadOptik win $10K. Appreciate your support!
https://t.co/hODW9dithP via @YouTube